Anterior chamber phakic IOL [the phakic 6] in the treatment of myopia and hypermetropia: 5-year follow-up

The aim of this study is to evaluate the efficacy and safety of anterior chamber phakic intraocular lenses in correcting high myopia and hypermetropia using the Safety Flex Phakic 6 anterior chamber intraocular lens [AC-IOL]. The study included 32 eyes [24 myopes and 8 hypermetropes]. The age ranged from 20 to 45 years. They we all phakic, with intact accommodation. They all underwent implantation of the Phakic 6 AC-IOL and they were followed-up for 5 years. Correction of the refractive error was achieved with a mean postoperative refractive error of -1.34D after one year which dropped to -1.95D after 5 years, and improvement of best corrected visual acuity was 17%. There were no significant complications and a high safety profile was achieved in the follow-up period. The phakic 6 proved to be a safe and effective method of correcting high myopia and hypermetropia according to the results of our study